Amanote Research

Amanote Research

    RegisterSign In

Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-10-0397
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

October 12, 2010

Authors
K. E. AllenG. J. Weiss
Publisher

American Association for Cancer Research (AACR)


Related search

Whole Blood microRNA Expression May Not Be Useful for Screening Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2017English

MicroRNA as Potential Biomarkers in Glioblastoma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2015English

Is Resistance Futile?

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2013English

Consensus May Not Be Systematic

Evidence-Based Dentistry
Dentistry
2002English

Screening for Herpes Simplex May Not Be Ethical

BMJ
2004English

New Antibiotics—Resistance Is Futile

PLoS Biology
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2004English

Biomarkers in Ovarian Cancer: To Be or Not to Be

Cancer
Cancer ResearchOncology
2019English

Neuropathy and Cough May Not Be a Fortuitous Association

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2014English

Pursuing Old Paths May Not Be Worthwhile

American Journal of Occupational Therapy
MedicineOccupational Therapy
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy